Range Financial Group LLC Acquires Shares of 489 Axon Enterprise, Inc. (NASDAQ:AXON)

Range Financial Group LLC bought a new position in Axon Enterprise, Inc. (NASDAQ:AXON) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 489 shares of the biotechnology company’s stock, valued at approximately $291,000.

Several other institutional investors have also bought and sold shares of AXON. TD Asset Management Inc grew its stake in Axon Enterprise by 11.9% during the second quarter. TD Asset Management Inc now owns 28,908 shares of the biotechnology company’s stock worth $8,506,000 after buying an additional 3,071 shares during the last quarter. National Bank of Canada FI boosted its holdings in shares of Axon Enterprise by 19.6% in the 2nd quarter. National Bank of Canada FI now owns 26,200 shares of the biotechnology company’s stock worth $7,577,000 after acquiring an additional 4,286 shares in the last quarter. Victory Capital Management Inc. grew its position in Axon Enterprise by 0.8% during the 2nd quarter. Victory Capital Management Inc. now owns 42,576 shares of the biotechnology company’s stock worth $12,528,000 after acquiring an additional 326 shares during the last quarter. Private Advisor Group LLC increased its holdings in Axon Enterprise by 5.8% during the 2nd quarter. Private Advisor Group LLC now owns 10,339 shares of the biotechnology company’s stock valued at $3,045,000 after purchasing an additional 571 shares in the last quarter. Finally, Cullen Frost Bankers Inc. bought a new position in Axon Enterprise in the 2nd quarter valued at $59,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Down 1.5 %

Shares of Axon Enterprise stock opened at $562.03 on Wednesday. Axon Enterprise, Inc. has a 12 month low of $244.01 and a 12 month high of $698.67. The business has a fifty day simple moving average of $598.56 and a 200 day simple moving average of $445.07. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a market cap of $42.86 billion, a PE ratio of 145.23, a price-to-earnings-growth ratio of 14.19 and a beta of 1.04.

Insider Transactions at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the transaction, the director now directly owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 51,545 shares of company stock worth $31,159,317. 6.10% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several brokerages have recently commented on AXON. Needham & Company LLC increased their target price on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. JMP Securities raised their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. Robert W. Baird upped their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Finally, Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and an average price target of $488.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.